Flavia H. Pease

Chief Financial Officer, Executive Vice President (Principal Financial Officer), Insulet Corporation

In the seat. First published here October 28, 2026; built from records as of October 28, 2026.

Flavia H. Pease signed the annual report of Insulet Corporation as Chief Financial Officer, Executive Vice President (Principal Financial Officer); the report was filed on February 18, 2026, the most recent filing in the record that ties Flavia H. Pease to the seat.¹

Seats

The seat in the record

Company	Title as filed	Standing	Filings
Insulet Corporation (PODD) Surgical & Medical Instruments & Apparatus	Chief Financial Officer, Executive Vice President (Principal Financial Officer)	In the seat	1

Company names link to the company's page in the record at CFO Tribune, which holds the seat history.

The record

Filing by filing, latest first

February 18, 202610-K filed
Flavia H. Pease signed the annual report of Insulet Corporation on Form 10-K as Chief Financial Officer, Executive Vice President (Principal Financial Officer), filed February 18, 2026.
/s/ Flavia H. Pease Flavia H. Pease Chief Financial Officer, Executive Vice President (Principal Financial Officer)
[1] Annual report on Form 10-K by Insulet Corporation, filed with the SEC on February 18, 2026. Read the filing. The record at CFO Tribune.

Sources

Annual report on Form 10-K, Insulet Corporation. U.S. Securities and Exchange Commission, EDGAR, filed February 18, 2026. sec.gov; record.

Corrections and removal

If a line here is wrong, or Flavia H. Pease wants this profile taken down, write to corrections@cfospotlights.com. Corrections are made on the page with a dated note; removal requests are answered within 72 hours. The underlying filings stay public at the SEC.